RSB Spine, a medical device company focused on developing modular fusion products for degenerative disc disease, has announced a 145 percent sales increase for the first quarter of 2011 compared to Q1 2010, according to a company news release.
Earlier this year, RSB Spine reported a 97 percent sales increase for fiscal year 2010 compared to FY 2009. Its continued sales growth can be attributed to its InterPlate platform, which is a load-bearing spinal implant that allows 1.8 mm of graft loading without stress shielding. The product allows surgeons to select the flush-fit interbody construct they want and to determine how that construct will behave, according to the release.
Read the company news release about RSB Spine's Q1 financial results.
Read other coverage about device company financial results:
- SANUWAVE Health Reports FY 2010 Revenues of $728K, 10.1% Increase
- BioMimetic Therapeutics Posts Flat 4Q Revenue at $400K
- Orthovita Reports 4Q Revenues of $23.4M, 4% Decrease
Earlier this year, RSB Spine reported a 97 percent sales increase for fiscal year 2010 compared to FY 2009. Its continued sales growth can be attributed to its InterPlate platform, which is a load-bearing spinal implant that allows 1.8 mm of graft loading without stress shielding. The product allows surgeons to select the flush-fit interbody construct they want and to determine how that construct will behave, according to the release.
Read the company news release about RSB Spine's Q1 financial results.
Read other coverage about device company financial results:
- SANUWAVE Health Reports FY 2010 Revenues of $728K, 10.1% Increase
- BioMimetic Therapeutics Posts Flat 4Q Revenue at $400K
- Orthovita Reports 4Q Revenues of $23.4M, 4% Decrease